Cyblex M 60XR Forte Tablet
By Cyblex M
Rx
15 Tablet ER in a Strip

Composition
Gliclazide(60mg) + Metformin(1000mg)

Manufacturer - Eris Lifesciences Ltd
8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after
May, 2026

liver
Cyblex M 60XR Forte Tablet needs to be used carefully in individuals with liver problems. It may be necessary to adjust the dosage of Cyblex M 60XR Forte Tablet for those with liver disease. It is advisable to consult your doctor before taking this medication. Typically, Cyblex M 60XR Forte Tablet is initiated with a low dose for patients with mild to moderate liver conditions. However, it is not advisable to use this tablet in individuals with severe liver disease. It is crucial to follow medical advice regarding the use of Cyblex M 60XR Forte Tablet if you have liver issues.

kidney
Cyblex M 60XR Forte Tablet should be used carefully in patients with kidney disease, and dose adjustment may be necessary. Avoid using it in severe kidney disease. Monitor your kidney function tests regularly during the treatment. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while taking Cyblex M 60XR Forte Tablet.

driving
Driving while taking Cyblex M 60XR Forte Tablet can be risky if your blood sugar levels are too high or too low. Avoid driving if you experience such symptoms.

pregnancy
Cyblex M 60XR Forte Tablet is considered unsafe during pregnancy, as it poses a definite risk to the developing baby. Only in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Cyblex M 60XR Forte Tablet may not be safe to use while breastfeeding. Limited data indicates potential harm to the baby through breastmilk transmission.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹143.47
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024